Epidemiology, pathophysiology and clinical outcomes for heart failure patients with a mid‐range ejection fraction

Publisher： John Wiley & Sons Inc

E-ISSN： 1879-0844|19|12|1597-1605

ISSN： 1388-9842

Source： EUROPEAN JOURNAL OF HEART FAILURE, Vol.19, Iss.12, 2017-12, pp. : 1597-1605

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Epidemiology and one‐year outcomes in patients with chronic heart failure and preserved, mid‐range and reduced ejection fraction: an analysis of the ESC Heart Failure Long‐Term Registry

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1574-1585

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure with mid‐range ejection fraction: a transition phenotype?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1635-1637

John Wiley & Sons Inc

Access to resources Recommend Favorite

A comprehensive population‐based characterization of heart failure with mid‐range ejection fraction

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1624-1634

John Wiley & Sons Inc

Access to resources Recommend Favorite

Heart failure with mid‐range ejection fraction: a distinct clinical entity? Insights from the Trial of Intensified versus standard Medical therapy in Elderly patients with Congestive Heart Failure (TIME‐CHF)

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1586-1596

John Wiley & Sons Inc

Access to resources Recommend Favorite

What have we learned about heart failure with mid‐range ejection fraction one year after its introduction?

By  

EUROPEAN JOURNAL OF HEART FAILURE, Vol. 19, Iss. 12, 2017-12 ,pp. : 1569-1573

John Wiley & Sons Inc

Access to resources Recommend Favorite